| Index | — | P/E | 14.36 | EPS (ttm) | 3.59 | Insider Own | 1.26% | Shs Outstand | 53.83M | Perf Week | 4.95% |
| Market Cap | 2.78B | Forward P/E | 10.01 | EPS next Y | 5.15 | Insider Trans | 1.99% | Shs Float | 53.61M | Perf Month | 2.71% |
| Enterprise Value | 4.73B | PEG | 0.89 | EPS next Q | 1.38 | Short Float | 4.41% | Perf Quarter | -12.46% | ||
| Income | 198.00M | P/S | 0.78 | EPS this Y | 15.75% | Short Ratio | 3.10 | Perf Half Y | -11.64% | ||
| Sales | 3.55B | P/B | 1.28 | EPS next Y | 6.22% | ROA | 3.64% | Short Interest | 2.37M | Perf YTD | -13.29% |
| Book/sh | 40.28 | P/C | 28.61 | EPS next 5Y | 16.20% | ROE | 9.51% | 52W High | 68.63 -26.87% | Perf Year | -10.25% |
| Cash/sh | 1.80 | P/FCF | 28.03 | EPS past 3/5Y | -5.51% 3.11% | ROIC | 6.57% | 52W Low | 46.70 7.47% | Perf 3Y | -21.09% |
| Dividend Est. | 0.98 (1.95%) | EV/EBITDA | 8.75 | Sales past 3/5Y | -2.51% 4.48% | Gross Margin | 32.79% | Volatility | 2.37% 2.39% | Perf 5Y | -26.66% |
| Dividend TTM | 0.97 (1.93%) | EV/Sales | 1.33 | EPS Y/Y TTM | — | Oper. Margin | 11.53% | ATR (14) | 1.41 | Perf 10Y | 17.72% |
| Dividend Ex-Date | Oct 15, 2026 | Quick Ratio | 1.10 | Sales Y/Y TTM | 1.48% | Profit Margin | 5.56% | RSI (14) | 56.63 | Recom | 2.40 |
| Dividend Gr. 3/5Y | 7.94% 7.45% | Current Ratio | 1.82 | EPS Q/Q | 20.63% | SMA20 | 2.57% | Beta | 0.97 | Target Price | 62.33 |
| Payout | 26.22% | Debt/Eq | 0.95 | Sales Q/Q | 5.16% | SMA50 | 0.20% | Rel Volume | 0.87 | Prev Close | 51.56 |
| Employees | 7,100 | LT Debt/Eq | 0.95 | Earnings | Jan 13 | SMA200 | -11.37% | Avg Volume | 762.32K | Price | 50.19 |
| IPO Date | Feb 21, 1973 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 3.74% -0.78% | Net Debt/EBITDA | 3.62 | Volume | 666,160 | Change | -2.66% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-21-26 | Reiterated | UBS | Neutral | $69 → $55 |
| Sep-29-26 | Reiterated | Deutsche Bank | Buy | $72 → $62 |
| Sep-25-26 | Reiterated | Robert W. Baird | $75 → $65 | |
| Jun-26-26 | Reiterated | UBS | Neutral | $71 → $69 |
| Jun-26-26 | Reiterated | Goldman Sachs | $67 | |
| Jun-26-26 | Reiterated | Raymond James | $67 | |
| Jun-26-26 | Upgrade | JP Morgan | Neutral → Overweight | |
| Jun-17-26 | Reiterated | UBS | Neutral | $58 → $71 |
| May-27-26 | Reiterated | UBS | Neutral | $63 → $58 |
| May-27-26 | Reiterated | RBC Capital | $58 |
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Building Adhesive Solutions. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives, such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven and hygiene, and medical and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives comprising reactive, light cure, two-part liquids, polyurethane, silicone, film, and fast cure products to the durable assembly, performance wood and textile, transportation, electronics, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly to customers, as well as through distributors and retailers in North America, Latin America, Europe, India, the Middle East, Africa, and the Asia Pacific. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 11/29/2025 | FY 2024 11/30/2024 | FY 2023 12/2/2023 | FY 2022 12/3/2022 | FY 2021 11/27/2021 | FY 2020 11/28/2020 | FY 2019 11/30/2019 | FY 2018 12/1/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,554 | 3,474 | 3,569 | 3,511 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 2,388 | 2,373 | 2,495 | 2,487 | — | — | — | — | — | |
| Gross Profit | 1,165 | 1,101 | 1,074 | 1,024 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 755 | 702 | 656 | 596 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 50 | 49 | — | — | — | — | — | |
| Other Operating Expense | 0 | 0 | -1 | -1 | — | — | — | — | — | |
| Operating Income | 410 | 399 | 369 | 379 | — | — | — | — | — | |
| Interest Expense | 140 | 133 | 133 | 135 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -3 | -47 | -49 | -6 | — | — | — | — | — | |
| Net Income Before Taxes | 267 | 219 | 187 | 239 | — | — | — | — | — | |
| Income Taxes | 70 | 67 | 56 | 94 | — | — | — | — | — | |
| Consolidated Net Income | 198 | 152 | 130 | 145 | — | — | — | — | — | |
| Net Income From Continuing Operations | 198 | 152 | 130 | 145 | — | — | — | — | — | |
| Net Income | 198 | 152 | 130 | 145 | — | — | — | — | — | |
| EPS (Recurring) | 3.64 | 2.78 | 2.37 | 2.67 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 3.64 | 2.78 | 2.37 | 2.67 | — | — | — | — | — | |
| EPS (Diluted) | 3.59 | 2.75 | 2.30 | 2.59 | — | — | — | — | — | |
| EBITDA | 541 | 527 | 490 | 529 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 13.98 | 21.19 | 33.43 | 29.69 | — | — | — | — | — | |
| Price To Sales Ratio | 0.76 | 0.92 | 1.18 | 1.18 | — | — | — | — | — | |
| Gross Margin | 32.78 | 31.69 | 30.09 | 29.17 | — | — | — | — | — | |
| Operating Margin | 11.54 | 11.49 | 10.34 | 10.79 | — | — | — | — | — | |
| Net Margin | 5.57 | 4.38 | 3.64 | 4.13 | — | — | — | — | — | |
| Shares Outstanding | 54 | 55 | 55 | 54 | — | — | — | — | — | |
| Market Capitalization | 2,710 | 3,205 | 4,229 | 4,152 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Malik Muhammad Shahbaz | Senior VP, BAS | Oct 16 '26 | Buy | 52.23 | 479 | 25,000 | 14,176 | Oct 19 |
| BAILLY R JEFFREY | Director | Oct 07 '26 | Buy | 50.00 | 10,000 | 500,000 | 10,000 | Oct 08 |
| Ogunsanya Gregory O. | Sr. VP, GC and Corp Secretary | Oct 04 '26 | Option Exercise | 50.20 | 655 | 32,881 | 6,925 | Oct 06 |
| Martin Celine Christine | Director | Sep 30 '26 | Buy | 49.50 | 465 | 22,998 | 465 | Oct 01 |
| Happe Michael J | Director | Sep 29 '26 | Buy | 49.63 | 2,000 | 99,250 | 3,343 | Oct 01 |
| Zaheer Srilata | Director | Sep 29 '26 | Buy | 49.97 | 40 | 1,999 | 3,386 | Sep 30 |
| Lauber Charles T | Director | Sep 29 '26 | Buy | 49.87 | 2,005 | 99,985 | 3,356 | Sep 30 |
| FLORNESS DANIEL L | Director | Sep 28 '26 | Buy | 49.34 | 2,030 | 100,160 | 3,381 | Sep 30 |
| Zaheer Srilata | Director | Sep 28 '26 | Buy | 49.06 | 2,000 | 98,120 | 3,346 | Sep 30 |
| Rasmussen Trangsrud Teresa J | Director | Sep 28 '26 | Buy | 48.96 | 2,042 | 99,984 | 4,053 | Sep 30 |
| HANDLEY THOMAS W | Director | Sep 28 '26 | Buy | 49.41 | 2,000 | 98,820 | 2,000 | Sep 30 |
| Rasmussen Trangsrud Teresa J | Director | Apr 17 '26 | Buy | 65.83 | 1,000 | 65,830 | 3,391 | Aug 18 |
| Weaver Nathan D. | Exec VP, Business Transform. | Aug 11 '26 | Option Exercise | 51.76 | 9,561 | 494,916 | 21,300 | Aug 12 |
| Weaver Nathan D. | Exec VP, Business Transform. | Aug 11 '26 | Sale | 62.06 | 9,561 | 593,332 | 11,739 | Aug 12 |
| Magalhaes Joao | Sr. VP, Engineering Adhesives | Jul 09 '26 | Option Exercise | 50.10 | 1,658 | 83,066 | 5,523 | Jul 10 |